SEC Fines COVID Test Maker, Execs Over Disclosures
By Sydney Price · July 5, 2023, 9:57 PM EDT
A molecular diagnostics company and its current and former executives have agreed to settle U.S. Securities and Exchange Commission claims that they issued two misleading press releases concerning a COVID-19 screening...
To view the full article, register now.